CDC vaccine recommendations stall after court blocks Kennedy’s panel

The CDC has not recommended the new mRNA flu vaccine mFlusiva, despite FDA approval for people ages 50 to 64. The agency said this month it would maintain last year’s flu vaccine endorsements, citing legal uncertainties and inquiries. Medical societies recommend the shot as an option.

Federal vaccine policy updates have stalled after Kennedy dismissed the Advisory Committee on Immunization Practices and replaced it with a new panel. In March, a federal judge said Kennedy likely violated federal procedures, stopped his panel from meeting and suspended his decision to reduce recommended vaccines for children. Doctors’ groups have since issued their own recommendations after private discussions. The CDC’s official guidance remains unchanged. The American Academy of Pediatrics is weighing changes to its HPV vaccine recommendations and could reach a conclusion later this year, according to James Campbell.